Published in J Clin Endocrinol Metab on July 01, 1975
Idiopathic hypopituitarism with biologically inactive TSH. Proc R Soc Med (1976) 0.95
Cytochemical methods of hormone assay. J Clin Pathol Suppl (Assoc Clin Pathol) (1976) 0.75
Cytochemistry in the bioassay of hormones. J Clin Pathol (1981) 0.75
Intrinsic bioactivity of thyrotropin in human serum is inversely correlated with thyroid hormone concentrations. Application of a new bioassay using the FRTL-5 rat thyroid cell strain. J Clin Invest (1987) 0.75
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
Addition of N-acetylcysteine to aqueous model bile systems accelerates dissolution of cholesterol gallstones. Gastroenterology (1990) 2.06
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings. The Critical Care Research Team. Crit Care Med (1992) 1.81
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
Oral "hairy" leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet (1984) 1.54
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50
Myopathy in acromegaly. Lancet (1970) 1.50
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48
The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47
Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
Hypothyroidism. Br Med J (1972) 1.41
Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39
Catheter ablation of the atrioventricular node using radiofrequency energy. Aust N Z J Med (1994) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics (2001) 1.38
Obstruction of bowel due to lesion in the myenteric plexus. Br Med J (1969) 1.37
Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.37
History of dermatology in Northern Ireland. Br J Dermatol (1970) 1.36
Characterization of myosin light chains from histochemically identified fibres of rabbit psoas muscle. FEBS Lett (1975) 1.35
The effect of calcium ions on the binomial statistic parameters which control acetylcholine release at synapses in striated muscle. J Physiol (1975) 1.33
Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology (2011) 1.33
Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite. Nature (1984) 1.33
Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology (1984) 1.32
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood (1986) 1.32
Further observations on the effect of synthetic thyrotropin-releasing hormone in man. Br Med J (1971) 1.32
Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies. Clin Chim Acta (1984) 1.31
Splenic size and function in adult coeliac disease. Br J Radiol (1980) 1.29
Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology. J Heart Valve Dis (1993) 1.29
Prediction of relapse in hyperthyroid Graves' disease. Lancet (1980) 1.27
Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27
Hearing loss due to mumps. Arch Dis Child (1987) 1.27
Measurement of thyrotropin receptor antibodies. Methods Enzymol (1981) 1.26
Ophthalmic Graves' disease. Diagnosis and pathogenesis. Lancet (1970) 1.26
Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Clin Endocrinol (Oxf) (1973) 1.25
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
Proteoglycans in dentinogenesis. Crit Rev Oral Biol Med (2001) 1.24
Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol (1983) 1.23
Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats. Lancet (1975) 1.23
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (1995) 1.21
Persistence of drug-resistant malaria parasites. Lancet (1978) 1.21
Thyroid stimulators in health and disease. Clin Endocrinol (Oxf) (1975) 1.21
Sites of autoantibody production in rats with thyroiditis. Immunology (1982) 1.21
Interaction between oxygen radicals and gastric mucin. Am J Physiol (1987) 1.21
Balloon dilatation of heart valves. BMJ (1992) 1.20
Postpartum thyroid dysfunction in Mid Glamorgan. Br Med J (Clin Res Ed) (1988) 1.20
The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology (1983) 1.19
Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol (1969) 1.19
Grades of hypothyroidism. Br Med J (1973) 1.18
Hormonal responses to synthetic luteinizing hormone and follicle stimulating hormone-releasing hormone in man. Br Med J (1972) 1.17
Hydrophobic binding properties of bovine gallbladder mucin. J Biol Chem (1984) 1.17
The comparative effects of sevoflurane versus propofol in the induction and maintenance of anesthesia in adult patients. Anesth Analg (1996) 1.16
Lung volumes and flow rates in black and white subjects. Thorax (1974) 1.16
Serum thyroglobulin: an early indicator of autoimmune post-partum thyroiditis. Clin Endocrinol (Oxf) (1994) 1.15